dr. W.J. Plattel

E-mail:
w.j.plattel umcg.nl
Research
1 - 17 out of 17Page size: 50
- 2020
- Reedijk, A. M. J., Zijtregtop, E. A. M., Coebergh, J. W. W., Meyer-Wentrup, F. A. G., Hebeda, K. M., Zwaan, C. M., Janssens, G. O. R., Pieters, R., Plattel, W. J., Dinmohamed, A. G., Zijlstra, J. M., Kremer, L. C. M., Lugtenburg, P. J., Beishuizen, A., & Karim-Kos, H. E. (2020). Improved survival for adolescents and young adults with Hodgkin lymphoma and continued high survival for children in the Netherlands: a population-based study during 1990-2015. British Journal of Haematology, 189(6), 1093-1106. https://doi.org/10.1111/bjh.16491
- Kahle, X. U., de Jesus, F. M. M., Glaudemans, A. W. J. M., Lub-de Hooge, M. N., Jorritsma-Smit, A., Plattel, W. J., van Meerten, T., Diepstra, A., van den Berg, A., Kwee, T. C., Noordzij, W., de Vries, E. G. E., & Nijland, M. (2020). Molecular imaging in lymphoma beyond F-18-FDG-PET: understanding the biology and its implications for diagnostics and therapy. Lancet Haematology, 7(6), E479-E489. https://doi.org/10.1016/S2352-3026(20)30065-X
- Driessen, J., Visser, O., Zijlstra, J. M., Lugtenburg, P. J., Plattel, W. J., Kersten, M. J., & Dinmohamed, A. G. (2020). Primary therapy and relative survival in classical Hodgkin lymphoma: a nationwide population-based study in the Netherlands, 1989-2017. Leukemia. https://doi.org/10.1038/s41375-020-0875-0
- Kersten, M. J., Driessen, J., Zijlstra, J. M., Plattel, W. J., Morschhauser, F., Lugtenburg, P. J., Brice, P., Hutchings, M., Gastinne, T., Liu, R., Burggraaff, C. N., Nijland, M., Tonino, S. H., Arens, A. I. J., Valkema, R., van Tinteren, H., Lopez-Yurda, M., Diepstra, A., De Jong, D., & Hagenbeek, A. (2020). Combining brentuximab vedotin with dexamethasone, high-dose cytarabine and cisplatin as salvage treatment in relapsed or refractory Hodgkin lymphoma: the phase II HOVON/LLPC Transplant BRaVE study. Haematologica. https://doi.org/10.3324/haematol.2019.243238
- Tan, G. W., Terpstra, M. M., Kok, K., Diepstra, A., van den Berg, A., & Plattel, W. (2020). Cell-free DNA as biomarker in Hodgkin lymphoma patients. Klinische Pädiatrie, 232(2), 89-89. https://doi.org/10.1055/s-0040-1701844
- Plattel, W. J., Visser, L., Diepstra, A., Glaudemans, A. W. J. M., Nijland, M., van Meerten, T., Kluin-Nelemans, H. C., van Imhoff, G. W., & van den Berg, A. (2020). Interim thymus and activation regulated chemokine versus interim F-18-fluorodeoxyglucose positron-emission tomography in classical Hodgkin lymphoma response evaluation. British Journal of Haematology, 190(1), 40-44. https://doi.org/10.1111/bjh.16514
- 2019
- Kahle, X. U., Montes de Jesus, F. M., Kwee, T. C., van Meerten, T., Diepstra, A., Rosati, S., Glaudemans, A. W. J. M., Noordzij, W., Plattel, W. J., & Nijland, M. (2019). Relationship between semiquantitative 18F-fluorodeoxyglucose positron emission tomography metrics and necrosis in classical Hodgkin lymphoma. Scientific Reports, 9(1), [11073]. https://doi.org/10.1038/s41598-019-47453-5
- Plattel, W. J. (2019). Circulating biomarkers in classical Hodgkin lymphoma. Rijksuniversiteit Groningen. https://doi.org/10.33612/diss.97631424
- 2017
- Klaassen, S. H. C., Lemmink, H. H., Bijzet, J., Glaudemans, A. W. J. M., Bos, R., Plattel, W., van den Berg, M. P., Slart, R. H. J. A., Nienhuis, H. L. A., van Veldhuisen, D. J., & Hazenberg, B. P. C. (2017). Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G). Cardiovascular Pathology, 29, 19-22. https://doi.org/10.1016/j.carpath.2017.04.002
- 2016
- Plattel, W. J., Alsada, Z. N. D., van Imhoff, G. W., Diepstra, A., van den Berg, A., & Visser, L. (2016). Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of sGalectin-1, sCD163 and sCD30 with TARC. British Journal of Haematology, 175(5), 868-875. https://doi.org/10.1111/bjh.14317
- 2014
- 2013
- Plattel, W., Kluiver, J., Diepstra, A., Visser, L., & van den Berg, A. (2013). The Role of MicroRNAs in Hodgkin's Lymphoma. In MicroRNAs in Medicine (pp. 435-447). Wiley-Blackwell. https://doi.org/10.1002/9781118300312.ch26
- 2012
- Xu, C., Plattel, W., van den Berg, A., Ruether, N., Huang, X., Wang, M., de Jong, D., Vos, H., van Imhoff, G., Viardot, A., Moeller, P., Poppema, S., Diepstra, A., & Visser, L. (2012). Expression of the c-Met oncogene by tumor cells predicts a favorable outcome in classical Hodgkin's lymphoma. Haematologica, 97(4), 572-578. https://doi.org/10.3324/haematol.2011.056101
- Plattel, W. J., van den Berg, A., Visser, L., van der Graaf, A-M., Pruim, J., Vos, H., Hepkema, B., Diepstra, A., & van Imhoff, G. W. (2012). Plasma thymus and activation-regulated chemokine as an early response marker in classical Hodgkin's lymphoma. Haematologica, 97(3), 410-415. https://doi.org/10.3324/haematol.2011.053199
- 2011
ID: 273122